Products

Mouse FGF13(Fibroblast Growth Factor 13) ELISA Kit
ELK6354
Size: Price:
48 T $320.00
96 T $458.00

Overview

Product name: Mouse FGF13(Fibroblast Growth Factor 13) ELISA Kit
Reactivity: Mouse
Alternative Names: FHF2; Fibroblast Growth Factor Homologous Factor 2
Assay Type: Sandwich
Sensitivity: 13.6 pg/mL
Standard: 2000 pg/mL
Detection Range: 31.25-2000 pg/mL
Sample Type: Serum, plasma and other biological fluids.
Assay Length: 3.5h
Research Area: Cytokine;
Uniprot ID: P70377
Test principle: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Mouse FGF13. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Mouse FGF13. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Mouse FGF13, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Mouse FGF13 in the samples is then determined by comparing the OD of the samples to the standard curve.

Standard curve

Concentration (pg/mL) OD Corrected OD
2000.00 2.045 1.959
1000.00 1.586 1.500
500.00 1.116 1.030
250.00 0.872 0.786
125.00 0.529 0.443
62.50 0.389 0.303
31.25 0.175 0.089
0.00 0.086 0.000

Precision

Intra-assay Precision (Precision within an assay):CV%<8%

Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

Inter-assay Precision (Precision between assays):CV%<10%

Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.

Recovery

Matrices listed below were spiked with certain level of recombinant FGF13 and the recovery rates were calculated by comparing the measured value to the expected amount of FGF13 in samples.
Matrix Recovery range Average
serum(n=5) 86-97% 92%
EDTA plasma(n=5) 84-103% 96%
Heparin plasma(n=5) 82-96% 87%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of FGF13 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Matrix 1:2 1:4 1:8 1:16
serum(n=5) 82-96% 85-98% 95-104% 82-96%
EDTA plasma(n=5) 81-93% 78-91% 87-98% 95-107%
Heparin plasma(n=5) 78-92% 79-93% 94-106% 83-97%